<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/css" href="http://owiki.kmu.edu.tw/skins/common/feed.css?63"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel>
		<title>Introduction of diabetic nephropathy - 修訂歷史</title>
		<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;action=history</link>
		<description>本站上此頁的修訂歷史</description>
		<language>zh-tw</language>
		<generator>MediaWiki 1.10.1</generator>
		<lastBuildDate>Sat, 04 Apr 2026 12:11:32 GMT</lastBuildDate>
		<item>
			<title>Guhjy在2018年3月27日 (二) 04:43</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;diff=24588&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月27日 (二) 04:43所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第10行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第10行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff| Lancet 1998;352:837. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff| Lancet 1998;352:837. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;**Intensive glycemic control prevents microangiopathy in newly diagnosed DM, but effects on macroangiopathy (cardiovascular diseases and atherosclerosis) are less certain&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**Intensive glycemic control &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(HbA1C 6.5~7%) &lt;/ins&gt;prevents microangiopathy in newly diagnosed DM, but effects on macroangiopathy (cardiovascular diseases and atherosclerosis) are less certain&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 27 Mar 2018 04:43:20 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Introduction_of_diabetic_nephropathy</comments>		</item>
		<item>
			<title>Guhjy在2018年3月27日 (二) 04:42</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;diff=24587&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月27日 (二) 04:42所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第11行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第11行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Intensive glycemic control prevents microangiopathy in newly diagnosed DM, but effects on macroangiopathy (cardiovascular diseases and atherosclerosis) are less certain&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Intensive glycemic control prevents microangiopathy in newly diagnosed DM, but effects on macroangiopathy (cardiovascular diseases and atherosclerosis) are less certain&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*Other risk factors of DN&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;**Hypertension (HT), proteinuria, smoking, hyperlipidemia, genetics (family history, renin-angiotensin gene polymorphism)&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 27 Mar 2018 04:42:58 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Introduction_of_diabetic_nephropathy</comments>		</item>
		<item>
			<title>Guhjy在2018年3月27日 (二) 04:42</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;diff=24586&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月27日 (二) 04:42所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第10行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第10行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff| Lancet 1998;352:837. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff| Lancet 1998;352:837. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;**&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Effects &lt;/del&gt;on macroangiopathy (cardiovascular &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;disease &lt;/del&gt;and atherosclerosis) are less certain&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Intensive glycemic control prevents microangiopathy in newly diagnosed DM, but effects &lt;/ins&gt;on macroangiopathy (cardiovascular &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;diseases &lt;/ins&gt;and atherosclerosis) are less certain&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*Other risk factors of DN&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;**Hypertension (HT), proteinuria, smoking, hyperlipidemia, genetics (family history, renin-angiotensin gene polymorphism)&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 27 Mar 2018 04:42:15 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Introduction_of_diabetic_nephropathy</comments>		</item>
		<item>
			<title>Guhjy在2018年3月13日 (二) 09:24</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;diff=24397&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月13日 (二) 09:24所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;***[http://content.nejm.org/cgi/content/short/329/14/977| NEJM 1993&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;:&lt;/del&gt;329:977. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;***[http://content.nejm.org/cgi/content/short/329/14/977| NEJM 1993&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;;&lt;/ins&gt;329:977. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff| Lancet 1998&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;:&lt;/del&gt;352:837. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff| Lancet 1998&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;;&lt;/ins&gt;352:837. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 13 Mar 2018 09:24:08 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Introduction_of_diabetic_nephropathy</comments>		</item>
		<item>
			<title>Guhjy在2018年3月13日 (二) 09:23</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;diff=24396&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月13日 (二) 09:23所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;***[http://content.nejm.org/cgi/content/short/329/14/977|NEJM 1993:329:977. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;***[http://content.nejm.org/cgi/content/short/329/14/977| NEJM 1993:329:977. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff|Lancet 1998:352:837. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff| Lancet 1998:352:837. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 13 Mar 2018 09:23:43 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Introduction_of_diabetic_nephropathy</comments>		</item>
		<item>
			<title>Guhjy在2018年3月13日 (二) 09:23</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;diff=24395&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月13日 (二) 09:23所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;***[http://content.nejm.org/cgi/content/short/329/14/977|NEJM 1993&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;;&lt;/del&gt;329:977&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;: &lt;/del&gt;The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;***[http://content.nejm.org/cgi/content/short/329/14/977|NEJM 1993&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;:&lt;/ins&gt;329:977&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. &lt;/ins&gt;The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff|Lancet 1998&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;;&lt;/del&gt;352:837&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;: &lt;/del&gt;Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff|Lancet 1998&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;:&lt;/ins&gt;352:837&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;. &lt;/ins&gt;Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 13 Mar 2018 09:23:03 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Introduction_of_diabetic_nephropathy</comments>		</item>
		<item>
			<title>Guhjy在2018年3月13日 (二) 09:22</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;diff=24394&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月13日 (二) 09:22所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;***&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[&lt;/del&gt;[http://content.nejm.org/cgi/content/short/329/14/977|NEJM 1993;329:977: The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;]&lt;/del&gt;]&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;***[http://content.nejm.org/cgi/content/short/329/14/977|NEJM 1993;329:977: The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff|Lancet 1998;352:837: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff|Lancet 1998;352:837: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 13 Mar 2018 09:22:15 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Introduction_of_diabetic_nephropathy</comments>		</item>
		<item>
			<title>Guhjy在2018年3月13日 (二) 09:21</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;diff=24393&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月13日 (二) 09:21所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第8行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第8行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***[[http://content.nejm.org/cgi/content/short/329/14/977|NEJM 1993;329:977: The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]]&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***[[http://content.nejm.org/cgi/content/short/329/14/977|NEJM 1993;329:977: The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*** &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[&lt;/del&gt;[http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff|Lancet 1998;352:837: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;|]&lt;/del&gt;]&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;*** [http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff|Lancet 1998;352:837: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 13 Mar 2018 09:21:19 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Introduction_of_diabetic_nephropathy</comments>		</item>
		<item>
			<title>Guhjy在2018年3月13日 (二) 09:20</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;diff=24392&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月13日 (二) 09:20所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;***&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;NEJM 1993;329:977: &lt;/del&gt;[[http://content.nejm.org/cgi/content/short/329/14/977|The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]]&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;***[[http://content.nejm.org/cgi/content/short/329/14/977|&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;NEJM 1993;329:977: &lt;/ins&gt;The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;*** [[http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6T1B-3TX4KPJ-3&amp;amp;_user=2411013&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_acct=C000051939&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=2411013&amp;amp;md5=6ce6fc1e30dcd65072e0b0bc72934dff|Lancet 1998;352:837: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)|]]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 13 Mar 2018 09:20:50 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Introduction_of_diabetic_nephropathy</comments>		</item>
		<item>
			<title>Guhjy在2018年3月13日 (二) 09:16</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Introduction_of_diabetic_nephropathy&amp;diff=24391&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月13日 (二) 09:16所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第6行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**DCCT (Diabetes Control and Complications Trial)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 1 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;***NEJM 1993;329:977: [[The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;|http://content.nejm.org/cgi/content/short/329/14/977&lt;/del&gt;]]&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;***NEJM 1993;329:977: [[&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;http://content.nejm.org/cgi/content/short/329/14/977|&lt;/ins&gt;The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus]]&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**UKPDS (UK Prospective Diabetes Study)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***Type 2 DM&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Tue, 13 Mar 2018 09:16:47 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Introduction_of_diabetic_nephropathy</comments>		</item>
	</channel>
</rss>